GD2 Specific CAR and Interleukin-15 Expressing Autologous NKT Cells to Treat Children With Neuroblastoma
Clinical trial NCT03294954 · RECRUITING
Trial details
- NCT number
- NCT03294954
- Sponsor
- Baylor College of Medicine
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-18
- Primary completion
- 2027-12-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.